RecruitingNCT07191561

Hepatic Lipid Metabolism-Alcohol Use Disorder

Mechanisms in Hepatic Lipid Metabolism in Alcohol Use Disorder: From Genomics, Transcriptomics to Metabolomics

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment

25 participants

Start Date

Jul 1, 2026

Study Type

OBSERVATIONAL

Conditions

Alcohol Use Disorder

Summary

Patients with hepatic steatosis due to alcohol will be offered liver biopsies when they enter a detoxification program. The first biopsy will occur in the first week of admission and the second in the fourth week when the steatosis has resolved. The hepatic transcriptome will be compared,

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Liver biopsy for people with alcohol use disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTLiver biopsy

Biopsy of the liver

Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07191561

Related Trials

Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)

NCT056773211 location

Alcohol Use Disorder and Cannabidiol

NCT056136081 location